HPH-15 administration significantly reduced these subsets (Fig. 5c) as well as the expression of Arg1 and Ym1 mRNAs, established markers of M2 macrophages, in the skin lesions of bleomycin-treated mice (Fig. 6a). The gene discussed is ARG1; the disease is neoplasm.